Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sergio Faria
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
pathologically proven diagnosis of adenocarcinoma of the prostate meeting one of the following conditions:
Clinical Stage \>T3 or
Gleason Score 8 or higher, or
PSA level \>20ng/ml
Study entry PSA must be obtained within 6 weeks prior to protocol entry
ECOG \<2
Age \>18
History and physical examination within 3 months
Bone scan and CT scan of the abdomen and pelvis within 3 months with no evidence of bone metastases and no pelvic lymph nodes larger than 1.0cm, unless biopsy negative.
CBC with differential within 6 weeks prior to protocol entry
Absolute neutrophil count \>2000cells/mm3
Hemoglobin \>8.0 g/dl (the use of transfusion to increase the Hg is acceptable)
Testosterone level within 6 weeks of protocol entry
Liver function tests
Signed informed consent
Prior use of hormonal therapy for prostate cancer is acceptable if less than 2 months.
You may not be if
Prior use of hormonal therapy for prostate cancer for more than 2 months. Previous use of finasteride or dutasteride is allowed.
Prior invasive malignancy (except non-melanoma skin) unless disease-free for more than 5 years.
